American Society of Hirudotherapy

Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review

Research article published in Molecules (Basel, Switzerland) (2017)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewClinical TrialsMinet et al. · Molecules (Basel, Switzerland), 2017

Abstract

A rapid and accurate diagnosis in patients with suspected heparin-induced thrombocytopenia (HIT) is essential for patient management but remains challenging. Current HIT diagnosis ideally relies on a combination of clinical information, immunoassay and functional assay results. Platelet activation assays or functional assays detect HIT antibodies that are more clinically significant. Several functional assays have been developed and evaluated in the literature. They differ in the activation endpoint studied; the technique or technology used; the platelet donor selection; the platelet suspension (washed platelets, platelet rich plasma or whole blood); the patient sample (serum or plasma); and the heparin used (type and concentrations). Inconsistencies in controls performed and associated results interpretation are common. Thresholds and performances are determined differently among papers. Functional assays suffer from interlaboratory variability. This lack of standardization limits the evaluation and the accessibility of functional assays in laboratories. In the present article, we review all the current activation endpoints, techniques and methodologies of functional assays developed for HIT diagnosis.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsBlood CoagulationBlood PlateletsHeparinHumansPlatelet ActivationPlatelet Function TestsReproducibility of ResultsSensitivity and SpecificityThrombocytopenia

Summary

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This review surveys the functional (platelet-activation) assays used to diagnose heparin-induced thrombocytopenia (HIT), detailing how they differ in endpoints, platelet sources, and methodology, and emphasizing that a lack of standardization and interlaboratory variability limit their accessibility. For the hirudotherapy evidence picture this matters as background on why heparin's immunologic complication, HIT, drives interest in non-heparin anticoagulants, including the direct thrombin inhibitor class to which the leech-derived molecule hirudin belongs. The caveat is significant: this is a methodological review of diagnostic assays that does not mention leeches, hirudin, or hirudotherapy, so it is purely supporting context, not evidence about leech-based treatment.

Citation

Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.

Minet et al. · Molecules (Basel, Switzerland), 2017

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.